Tomorrow is #WorldCancerDay. Behind every cancer diagnosis lies a unique human story – stories of joy and grief, healing and pain, resilience and setbacks. That’s why a people-centered approach to cancer care that combines each unique need with compassion and empathy can lead to

Virologist Harald zur Hausen discovered how cervical cancer is triggered by virus infections. His work led to the creation of the HPV vaccine which cuts the risk of developing cervical cancer. #WorldCancerDay

Those who have beat it. Those we have lost to it. Those who are fighting. True warriors. 🤍💫🙏🏼 #WorldCancerDay

It's #WorldCancerDay. Here are ways to reduce your #cancer risk: 🚭Don't use tobacco 🏃🏽‍♂️Exercise regularly and be physically active ✅Keep a healthy weight 🥗Eat a healthy diet with a variety of fruit and vegetables 🕶Avoid strong sunlight for prolonged periods and limit

#WorldCancerDay #RadiationOncology #UnitedByUnique #RadiotherapySavesLives #AIRO #ESTRO #ASTRO

🗓️ Febbraio è il mese dedicato alle 𝗠𝗮𝗹𝗮𝘁𝘁𝗶𝗲 𝗥𝗮𝗿e. Tra queste, i 𝗧𝘂𝗺𝗼𝗿𝗶 𝗥𝗮𝗿𝗶 rappresentano una sfida significativa: progetto 𝗥𝗔𝗥𝗘𝗖𝗔𝗥𝗘𝗻𝗲𝘁 (lnkd.in/dufyQBCe) #RareButNotAlone #TumoriRari #RadioterapiaOncologica

𝗥𝗔𝗥𝗘𝗖𝗔𝗥𝗘𝗻𝗲𝘁 (lnkd.in/dufyQBCe) #RareButNotAlone #RareCancers #RadiationOncology #RadiotherapySavesLives #RareDiseaseDay #RareDiseasesEurope #AIRO

🚀Paradigm Shift in Oligometastatic Prostate Cancer? SBRT + ADT Doubles Progression-Free Survival! OncoAlert 🎯 Objective Does adding 6 months of ADT to SBRT ⬆️clinical progression-free survival (cPFS) vs. SBRT alone? 🏥 Methods •Ph2, randomized trial (105 👥, Milan, Italy)

We look forward to meeting you all in #Vienna at #ESTROCommunitiesPavilion (booth CP12) 🤝 AIRO - Associazione Italiana di Radioterapia ed Oncologia Clinica AIRO Giovani European Society for Radiotherapy and Oncology ESTRO #ESTRO25 #RadiationOncology #CancerResearch

Limited edition Radiation Oncologist action figure complete with accessories. Get yours before they run out! #astro #radonc

Proud of co-chairing with ESMO - Eur. Oncology President Elect G Curigliano MD PhD the ESMO-ESTRO joint session on combinatory strategies between #Radiotherapy and new system therapies Transformative innovation through partnership💪🏼💪🏼 #ESTRO25 OncoAlert #radonc #medonc ESTRO #OncoAlert

#ESTRO25 Press release:  Two-Week Radiotherapy Proven as Safe and Effective as Eight-Week Course for #ProstateCancer, After 10-Year Follow-Up in Phase III Trial. 👉 bit.ly/3RNnw3B

📢 PERSIAN TRIAL presented by Giulio Francolini shows that metachronous HSPC patients with <3 metastases benefitted from Apa+ADT+SBRT compared to Apa+ADT #ESTRO2025

📢 Imaging findings from the THUNDER trial (NCT06282588) at #ESTRO25: Fleur Kleiburg! 💡PSMA PET/CT upstaged 30% of high-risk #ProstateCancer, with 13% reclassified as M1 (x2 proPSMA). 🧬Genomic Classifier scores independently predict extraprostatic disease on PSMA PET.

🇫🇷 National Societies Network 🇮🇹 💪🏼 A super inspiring meetup during #ESTRO2025 with SFjRO-Société Française des Jeunes Radiothérapeutes Oncologues, a great moment of exchange between #young radiation oncologists! SFjRO 🚀 The #future of #radiationoncology also starts here!

#PERSIAN trial explores SBRT benefits in oligometastatic hormone-sensitive #ProstateCancer. Giulio Francolini Azienda Ospedaliero-Universitaria Careggi sits down with Neeraj Agarwal, MD, FASCO Huntsman Cancer Institute to discuss SBRT added to ADT plus apalutamide in oligometastatic #HSPC. Preliminary analysis of 87 patients shows a

𝗜𝗟 𝗙𝗨𝗧𝗨𝗥𝗢 𝗗𝗘𝗟𝗟𝗔 𝗥𝗔𝗗𝗜𝗢𝗧𝗘𝗥𝗔𝗣𝗜𝗔: 𝗙𝗢𝗥𝗠𝗔𝗭𝗜𝗢𝗡𝗘, 𝗥𝗜𝗖𝗘𝗥𝗖𝗔 𝗘 𝗜𝗡𝗡𝗢𝗩𝗔𝗭𝗜𝗢𝗡𝗘 📍 𝗥𝗼𝗺𝗮 📅 𝗠𝗲𝗿𝗰𝗼𝗹𝗲𝗱𝗶̀ 𝟮𝟭 𝗠𝗮𝗴𝗴𝗶𝗼 𝟮𝟬𝟮𝟱, ore 10.00 🛜 #direttastreaming dalla Web TV del Senato della Repubblica: lnkd.in/d9kvt2Mu

AIRO 2025⏳ ⏳ ⏳ lnkd.in/dFZfU52w [email protected] #AIRO2025 #radioterapiaoncologica #curadiprecisione

🚭World No Tobacco Day #AIRO #WNTD2025 #TobaccoExposed #UnmaskTheAppeal

🚨 New data from the phase 2 EXTEND trial: Adding metastasis-directed therapy to ADT doubles progression-free survival in oligometastatic prostate cancer vs ADT alone (36 vs 17 mo). 📈 Immune activation also boosted—T-cell response may be key. 🔬 ⁉️What about MDT+ARPI vs